A trial looking at volrustomig for head and neck cancer that has spread into the surrounding tissue (eVOLVE-HNSCC)

This trial is looking at volrustomig (MEDI5752) for head and neck cancer that has spread into the surrounding tissue and cannot be removed by surgery.

Cancer that has spread into the surrounding tissue is called locally advanced cancer.

It is open to people who have had chemotherapy alongside radiotherapy (chemoradiotherapy) as treatment for the following:

• oropharyngeal cancer

• mouth (oral) cancer

• hypopharyngeal cancer

• laryngeal cancer

• tongue cancer

• tonsil cancer

You pronounce volrustomig as vole-rust-oh-mig.